Pharmabiz2h
Bry-Air conducts 14th Biannual Eye Camp at Moga, Punjab, to celebrate 60 years of the company
Bry-Air conducts 14th Biannual Eye Camp at Moga, Punjab, to celebrate 60 years of the company: Our Bureau, Mumbai Wednesday, ...
Pharmabiz8m
Abbott announces first step toward its software-guided balloon-expandable TAVI System to treat aortic stenosis
Abbott announces first step toward its software-guided balloon-expandable TAVI System to treat aortic stenosis: Abbott Park, Illinois Wednesday, November 27, 2024, 16:00 Hrs [IST] ...
Pharmabiz1h
J INTS BIO, MD Anderson develop ‘JIN-001' for brain tumour treatment to enhance radiation and chemotherapy efficacy
J INTS BIO, MD Anderson develop ‘JIN-001' for brain tumour treatment to enhance radiation and chemotherapy efficacy: Seoul, South Korea Wednesday, November 27, 2024, 15:00 Hrs [ ...
Pharmabiz1h
Johnson & Johnson unveils ‘India Detects to Defeat’ initiative to urge for early lung cancer detection and testing
Johnson & Johnson (J&J) India announced the launch of its nationwide campaign, India Detects to Defeat, highlighting the critical role of early detection and testing in improving lung cancer outcomes.
Pharmabiz2h
Philips advances remote imaging leadership with US FDA 510(k) clearance for innovative remote scanning and protocol management capabilities
Royal Philips, a global leader in health technology, announced a major step forward in making radiology expertise for diagnostic imaging accessible to more patients. The US Food and Drug ...
Pharmabiz1h
Centrum addresses growing joint health concerns with launch of Centrum Joint & Mobility Capsule in India
Centrum addresses growing joint health concerns with launch of Centrum Joint & Mobility Capsule in India: Our Bureau, Mumbai Wednesday, November 27, 2024, 14:30 Hrs [IST] Centrum, ...
Pharmabiz2h
Rajesh Narvekar takes charge as Maharashtra FDA Commissioner
The Maharashtra government has appointed Rajesh Narvekar as the new Commissioner of the Food and Drug Administration (FDA), Maharashtra. Narvekar officially assumed charge last week, filling a post ...
Pharmabiz4h
Empyrean Therapeutics acquires TLR-2 antagonist molecule from Eos Therapies to advance and commercialize breakthrough cancer treatment
Empyrean Therapeutics acquires TLR-2 antagonist molecule from Eos Therapies to advance and commercialize breakthrough cancer treatment: Boca Raton, Florida Wednesday, November 27, ...
Pharmabiz3h
Glenmark Pharmaceuticals introduces travoprost ophthalmic solution USP, 0.004% in US
Glenmark Pharmaceuticals Inc., USA (Glenmark) announced the launch of travoprost ophthalmic solution USP, 0.004% (ionic buffered solution). Glenmark’s travoprost ophthalmic solution USP, 0.004% is ...
Pharmabiz5h
ReviR Therapeutics & Kennedy's Disease Association partner to advance treatment for rare neuromuscular disorder
ReviR Therapeutics, a pioneering biotechnology company focused on developing novel small molecule RNA modulators for neurogenetic diseases, announced a groundbreaking research grant from the Kennedy's ...
Pharmabiz6h
Boehringer Ingelheim introduces US FDA approved VETMEDIN Solution for congestive heart failure in dogs
Boehringer Ingelheim introduces US FDA approved VETMEDIN Solution for congestive heart failure in dogs: Ingelheim Wednesday, November 27, 2024, 10:00 Hrs [IST] Boehringer Ingelhei ...
Pharmabiz7h
Roche inks agreement to acquire clinical-stage biopharma company, Poseida Therapeutics
Roche inks agreement to acquire clinical-stage biopharma company, Poseida Therapeutics: Basel Wednesday, November 27, 2024, 09:00 Hrs [IST] Roche announced that it has entered int ...